This proposed mechanism explains how FH mutations can increase the risk of developing leiomyomas of the uterus or skin, uterine leiomyosarcoma, and renal cell carcinoma (4, 5). This evidence concerns the gene FH and hereditary clear cell renal cell carcinoma.